These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21570123)

  • 1. Risk factors of hepatitis during anti-tuberculous treatment and implications of hepatitis virus load.
    Wang JY; Liu CH; Hu FC; Chang HC; Liu JL; Chen JM; Yu CJ; Lee LN; Kao JH; Yang PC
    J Infect; 2011 Jun; 62(6):448-55. PubMed ID: 21570123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
    Laurent C; Bourgeois A; Mpoudi-Ngolé E; Kouanfack C; Ciaffi L; Nkoué N; Mougnutou R; Calmy A; Koulla-Shiro S; Ducos J; Delaporte E
    HIV Med; 2010 Jan; 11(1):85-9. PubMed ID: 19659944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline HBV load increases the risk of anti-tuberculous drug-induced hepatitis flares in patients with tuberculosis.
    Zhu CH; Zhao MZ; Chen G; Qi JY; Song JX; Ning Q; Xu D
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):105-109. PubMed ID: 28224437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles.
    Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM
    Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine deaminase activity in serum of patients with hepatitis -- a useful tool in monitoring clinical status.
    Kaya S; Cetin ES; Aridogan BC; Arikan S; Demirci M
    J Microbiol Immunol Infect; 2007 Aug; 40(4):288-92. PubMed ID: 17712462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of hepatitis B and C virus infection on graft function after renal transplantation.
    Behzad-Behbahani A; Mojiri A; Tabei SZ; Farhadi-Andarabi A; Pouransari R; Yaghobi R; Rahsaz M; Banihashemi M; Malek-Hosseini SA; Javid A; Bahador A; Reisjalali A; Behzadi S; Salehipour M; Salahl A; Davari R; Janghorban P; Torb A; Salah AR
    Transplant Proc; 2005 Sep; 37(7):3045-7. PubMed ID: 16213299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance characteristics and results of a large-scale screening program for viral hepatitis and risk factors associated with exposure to viral hepatitis B and C: results of the National Hepatitis Screening Survey. National Hepatitis Surveillance Group.
    Kaur S; Rybicki L; Bacon BR; Gollan JL; Rustgi VK; Carey WD
    Hepatology; 1996 Nov; 24(5):979-86. PubMed ID: 8903363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study.
    Sungkanuparph S; Vibhagool A; Manosuthi W; Kiertiburanakul S; Atamasirikul K; Aumkhyan A; Thakkinstian A
    J Med Assoc Thai; 2004 Nov; 87(11):1349-54. PubMed ID: 15825712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occult hepatitis B virus infection in hemodialysis patients with chronic HCV infection.
    Siagris D; Christofidou M; Triga K; Pagoni N; Theocharis GJ; Goumenos D; Lekkou A; Thomopoulos K; Tsamandas AC; Vlachojannis J; Labropoulou-Karatza C
    J Nephrol; 2006; 19(3):327-33. PubMed ID: 16874693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
    Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
    J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of association between occult hepatitis B virus DNA viral load and aminotransferase levels in patients with hepatitis C virus-related chronic liver disease.
    Fujiwara K; Tanaka Y; Orito E; Ohno T; Kato T; Sugauchi F; Suzuki S; Hattori Y; Sakurai M; Hasegawa I; Ozasa T; Kanie F; Kano H; Ueda R; Mizokami M
    J Gastroenterol Hepatol; 2004 Dec; 19(12):1343-7. PubMed ID: 15610306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of hepatitis C and B infection and HC V genotypes among hemodialysis patients in Khuzestan province, southwest Iran.
    Assarehzadegan MA; Shakerinejad G; Noroozkohnejad R; Amini A; Rahim Rezaee SA
    Saudi J Kidney Dis Transpl; 2009 Jul; 20(4):681-4. PubMed ID: 19587521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study.
    Loras C; Saro C; Gonzalez-Huix F; Mínguez M; Merino O; Gisbert JP; Barrio J; Bernal A; Gutiérrez A; Piqueras M; Calvet X; Andreu M; Abad A; Ginard D; Bujanda L; Panés J; Torres M; Fernández-Bañares F; Viver JM; Esteve M;
    Am J Gastroenterol; 2009 Jan; 104(1):57-63. PubMed ID: 19098850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High prevalence of HBV and HCV infection among intravenous drug users in Korea.
    Yun H; Kim D; Kim S; Kang S; Jeong S; Cheon Y; Joe K; Gwon DH; Cho SN; Jee Y
    J Med Virol; 2008 Sep; 80(9):1570-5. PubMed ID: 18649342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.
    Kovari H; Ledergerber B; Battegay M; Rauch A; Hirschel B; Foguena AK; Vernazza P; Bernasconi E; Mueller NJ; Weber R
    Clin Infect Dis; 2010 Feb; 50(4):502-11. PubMed ID: 20085465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology of hepatitis B, C, D and E viruses among children in Moscow, Russia.
    Abe K; Hayakawa E; Sminov AV; Rossina AL; Ding X; Huy TT; Sata T; Uchaikin VF
    J Clin Virol; 2004 May; 30(1):57-61. PubMed ID: 15072755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
    J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
    Miyasaka M
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.